
Keywords: ادم ماکولا دیابتی; AE; adverse event; BCVA; best-corrected visual acuity; CI; confidence interval; CRT; central retinal thickness; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; FAS; full analysis set; PRN; pro re nata; RELIGHT; Ranibizumab